113 related articles for article (PubMed ID: 15004336)
1. Tumorigenesis of murine erythroleukemia cell line transfected with exogenous p53 gene.
Sun D; Wang J; Yao W; Gu L; Wen Z; Shu C
Clin Hemorheol Microcirc; 2004; 30(2):117-26. PubMed ID: 15004336
[TBL] [Abstract][Full Text] [Related]
2. Exogenous wild-type p53 gene improved survival of nude mice injected with murine erythroleukemia cell line through amelioration of hemorheological changes.
Zhang Y; Yao W; Zeng Z; Wang X; Sun D; Ka W; Zhou S; He D; Wen Z; Chien S
Microcirculation; 2007 Feb; 14(2):155-66. PubMed ID: 17365670
[TBL] [Abstract][Full Text] [Related]
3. Wild type p53 gene causes reorganization of cytoskeleton and, therefore, the impaired deformability and difficult migration of murine erythroleukemia cells.
Yao W; Gu L; Sun D; Ka W; Wen Z; Chien S
Cell Motil Cytoskeleton; 2003 Sep; 56(1):1-12. PubMed ID: 12905527
[TBL] [Abstract][Full Text] [Related]
4. Alterations in hemorheological properties of erythrocytes in nude mice with erythroleukemia and the treatment effects of etoposide.
Xu X; Zeng Z; Yao W; Sun D; Ka W; Zhou S; Wen Z
Clin Hemorheol Microcirc; 2005; 33(4):347-61. PubMed ID: 16317244
[TBL] [Abstract][Full Text] [Related]
5. Effects of TFAR19 gene on the in vivo biorheological properties and pathogenicity of mouse erythroleukemia cell line MEL.
Gu L; Tang Z; He D; Ka W; Sun D; Wen Z
Sci China C Life Sci; 2007 Feb; 50(1):111-9. PubMed ID: 17393091
[TBL] [Abstract][Full Text] [Related]
6. [FTIR spectroscopy studies on the apoptosis-promoting effect of TFAR19 on the erythroleukemia cell line MEL].
Gu L; Xie L; Yao W; Ka W; Sun D; Wen Z
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):449-52. PubMed ID: 15250154
[TBL] [Abstract][Full Text] [Related]
7. [Pathological studies on the anti-invasive character of IL-6 gene transfected leukemia cells].
Ge L; Cao X; Ma D
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):409-11. PubMed ID: 8697988
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene.
Murakami T; Tokunaga N; Waku T; Gomi S; Kagawa S; Tanaka N; Fujiwara T
Clin Cancer Res; 2004 Jun; 10(11):3871-80. PubMed ID: 15173096
[TBL] [Abstract][Full Text] [Related]
9. Functional domains of c-Myc involved in the commitment and differentiation of murine erythroleukemia cells.
Ohmori Y; Tanabe J; Takada S; Lee WM; Obinata M
Oncogene; 1993 Feb; 8(2):379-86. PubMed ID: 8426744
[TBL] [Abstract][Full Text] [Related]
10. [Differentiation and malignant suppression induced by mouse erythroid differentiation and denucleation factor on mouse erythroleukemia cells].
Zhao Q; Ge YH; Zhou JP; Ma J; Chen KQ; Xue SP; Han DS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb; 23(1):32-5. PubMed ID: 12905814
[TBL] [Abstract][Full Text] [Related]
11. A novel system to identify Myb target promoters in friend murine erythroleukemia cells.
Chen J; Bender TP
Blood Cells Mol Dis; 2001; 27(2):429-36. PubMed ID: 11500057
[TBL] [Abstract][Full Text] [Related]
12. Spi-1 transgenic mice develop a clonal erythroleukemia which does not depend on p53 mutation.
Barnache S; Wendling F; Lacombe C; Denis N; Titeux M; Vainchenker W; Moreau-Gachelin F
Oncogene; 1998 Jun; 16(23):2989-95. PubMed ID: 9662331
[TBL] [Abstract][Full Text] [Related]
13. [Autoradiographic study of the proliferative activity of bone marrow, spleen and liver cells in healthy mice and in mice with Rauscher virus-induced erythroleukemia].
Rusev RV; Kancheva LS; Mladenov ZM
Eksp Onkol; 1986; 8(6):24-7. PubMed ID: 3467965
[TBL] [Abstract][Full Text] [Related]
14. Hemorheological follow-up after splenectomy and spleen autotransplantation in mice.
Miko I; Nemeth N; Sipka S; Brath E; Peto K; Gulyas A; Furka I; Zhong R
Microsurgery; 2006; 26(1):38-42. PubMed ID: 16444721
[TBL] [Abstract][Full Text] [Related]
15. A new human acute monocytic leukemia cell line SHI-1 with t(6;11)(q27;q23), p53 gene alterations and high tumorigenicity in nude mice.
Chen S; Xue Y; Zhang X; Wu Y; Pan J; Wang Y; Ceng J
Haematologica; 2005 Jun; 90(6):766-75. PubMed ID: 15951289
[TBL] [Abstract][Full Text] [Related]
16. Murine mammary adenocarcinoma cells transfected with p53 and/or Flt3L induce antitumor immune responses.
Sang H; Pisarev VM; Chavez J; Robinson S; Guo Y; Hatcher L; Munger C; Talmadge CB; Solheim JC; Singh RK; Talmadge JE
Cancer Gene Ther; 2005 Apr; 12(4):427-37. PubMed ID: 15678151
[TBL] [Abstract][Full Text] [Related]
17. Effect of p53 haploinsufficiency on melphalan-induced genotoxic effects in mouse bone marrow and peripheral blood.
Ranaldi R; Palma S; Tanzarella C; Lascialfari A; Cinelli S; Pacchierotti F
Mutat Res; 2007 Feb; 615(1-2):57-65. PubMed ID: 17109898
[TBL] [Abstract][Full Text] [Related]
18. In vivo expression and antitumor activity of p53 gene transfer with naked plasmid DNA in an ovarian cancer xenograft model in nude mice.
Collinet P; Vereecque R; Sabban F; Vinatier D; Leblanc E; Narducci F; Querleu D; Quesnel B
J Obstet Gynaecol Res; 2006 Oct; 32(5):449-53. PubMed ID: 16984510
[TBL] [Abstract][Full Text] [Related]
19. Murine erythroleukemia (MEL) cells bear ligands for the sialoadhesin and erythroblast receptor macrophage hemagglutinins.
Fraser IP; Gordon S
Eur J Cell Biol; 1994 Aug; 64(2):217-21. PubMed ID: 7813510
[TBL] [Abstract][Full Text] [Related]
20. TFAR19 gene changes the biophysical properties of murine erythroleukemia cells.
Gu L; Jiang Y; Wang Y; Yao W; Sun D; Ka W; Tang Z; Xu X; Wen Z; Chien S
Cell Biochem Biophys; 2005; 43(3):355-63. PubMed ID: 16247177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
